All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. [Practice pattern variation in the treatment of acute myocardial infarction in Belgian hospitals]

    KCE Reports 14 (2005)

    https://kce.fgov.be/en/practice-pattern-variation-in-the-treatment-of-acute-myocardial-infarction-in-belgian-hospitals

  2. [Rapid Assessment: Cardiovascular Primary Prevention in the Belgian General Practice]

    KCE Reports 52 (2007)

    https://kce.fgov.be/en/rapid-assessment-cardiovascular-primary-prevention-in-the-belgian-general-practice

  3. The Implantable Cardioverter Defibrillator: a Health Technology Assessment

    KCE Reports 58 (2007)

    https://kce.fgov.be/en/the-implantable-cardioverter-defibrillator-a-health-technology-assessment

  4. Drug Eluting Stents in Belgium: Health Technology Assessment

    KCE Reports 66 (2007)

    https://kce.fgov.be/en/drug-eluting-stents-in-belgium-health-technology-assessment

  5. 64-Slice computed tomography imaging of coronary arteries in patients suspected for coronary artery disease

    KCE Reports 82 (2008)

    https://kce.fgov.be/en/64-slice-computed-tomography-imaging-of-coronary-arteries-in-patients-suspected-for-coronary-artery

  6. Percutaneous heart valve implantation in congenital and degenerative valve disease. A rapid Health Technology Assessment.

    KCE Reports 95 (2008)

    https://kce.fgov.be/en/percutaneous-heart-valve-implantation-in-congenital-and-degenerative-valve-disease-a-rapid-health

  7. Remote monitoring for patients with implanted defibrillators. Technology evaluation and broader regulatory framework

    KCE Reports 136 (2010)

    https://kce.fgov.be/en/remote-monitoring-for-patients-with-implanted-defibrillators-technology-evaluation-and-broader

  8. Pacemaker therapy for bradycardia in belgium

    KCE Reports 137A (2010)

    https://kce.fgov.be/en/pacemaker-therapy-for-bradycardia-in-belgium

  9. [Statins in Belgium: utilization trends and impact of reimbursement policies]

    KCE Reports 141 (2010)

    https://kce.fgov.be/en/statins-in-belgium-utilization-trends-and-impact-of-reimbursement-policies

  10. Cardiac resynchronisation therapy. A health technology assessment

    KCE Reports 145 (2010)

    https://kce.fgov.be/en/cardiac-resynchronisation-therapy-a-health-technology-assessment

  11. Transcatheter Aortic Valve Implantation (TAVI): a Health Technology Assessment Update

    KCE Reports 163 (2011)

    https://kce.fgov.be/en/transcatheter-aortic-valve-implantation-tavi-a-health-technology-assessment-update

  12. Diagnosis and treatment of varicose veins in the legs

    KCE Reports 164 (2011)

    https://kce.fgov.be/en/diagnosis-and-treatment-of-varicose-veins-in-the-legs
  13. R184

    Catheter ablation of atrial fibrillation

    KCE Reports 184 (2012)

    https://kce.fgov.be/en/catheter-ablation-of-atrial-fibrillation

  14. General framework for a multidisciplinary quality manual for cardiac care networks

    KCE Reports 213 (2013)

    https://kce.fgov.be/en/general-framework-for-a-multidisciplinary-quality-manual-for-cardiac-care-networks

  15. Revascularization for lower limb peripheral arterial disease

    KCE Reports 221 (2014)

    https://kce.fgov.be/en/revascularization-for-lower-limb-peripheral-arterial-disease
  16. CP241

    Cardiovascular pre-participation screening in young athletes

    KCE Reports 241 (2015) About 1 million young Belgians (14-34) are member of a sportsclub, and in addition, many others are practicing a sport outside the structure of a sport organization. As we all know, sport is very good for your health. But, unfortunately, but luckily very seldom, it can lead to a sudden death due to cardiac failure. The authorities already have made a lot of effort to limit the risk for sporters. But can we avoid this kind of shocking events by submitting young sporters, without heart complaints, to a systematic heart examination?

    https://kce.fgov.be/en/cardiovascular-pre-participation-screening-in-young-athletes
  17. Senior couple on contry bike

    Statins for the primary prevention of cardiovascular events

    KCE Reports 306 (2019) A healthy lifestyle remains the most effective way of avoiding cardiovascular diseases and their consequences. Yet since 2002, the annual number of people who use cholesterol-lowering drugs from the statin family increased from 400,000 to 1,500,000. Currently, 25% of the population aged 40 and above take these drugs. Despite decreases in price due to the fact that all statins now exist in generic form, their total cost still stands at 160 million euros annually.

    https://kce.fgov.be/en/statins-for-the-primary-prevention-of-cardiovascular-events